REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 107 filers reported holding REPLIMUNE GROUP INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,380,828 | -32.1% | 80,703 | -7.9% | 0.00% | -50.0% |
| Q2 2023 | $2,033,654 | -15.4% | 87,582 | -35.7% | 0.00% | -33.3% |
| Q1 2023 | $2,404,215 | -31.5% | 136,139 | +5.6% | 0.00% | -25.0% |
| Q4 2022 | $3,507,957 | +992.8% | 128,969 | +581.6% | 0.00% | – |
| Q1 2022 | $321,000 | -91.3% | 18,922 | -84.4% | 0.00% | -100.0% |
| Q1 2021 | $3,700,000 | -9.5% | 121,257 | +13.2% | 0.00% | 0.0% |
| Q4 2020 | $4,088,000 | +534.8% | 107,159 | +282.8% | 0.00% | +300.0% |
| Q3 2020 | $644,000 | – | 27,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |